Shares of Aurora Cannabis (NYSE: ACB) jumped more than 14% on Thursday. Aurora's net revenue, excluding provisions, leapt 18% sequentially to 78.4 million Canadian dollars, driven by a 24% rise in recreational consumer cannabis sales and a 13.5% increase in medical cannabis revenue. "I am incredibly proud of the Aurora team for working through these challenging times in order to maintain uninterrupted operations at all of our production facilities and ensure we continue to meet the needs of our patients and consumers," Executive Chairman and Interim CEO Michael Singer said in a press release. Read More...
Shares of Aurora Cannabis (NYSE: ACB) jumped more than 14% on Thursday. Aurora’s net revenue, excluding provisions, leapt 18% sequentially to 78.4 million Canadian dollars, driven by a 24% rise in recreational consumer cannabis sales and a 13.5% increase in medical cannabis revenue. “I am incredibly proud of the Aurora team for working through these challenging times in order to maintain uninterrupted operations at all of our production facilities and ensure we continue to meet the needs of our patients and consumers,” Executive Chairman and Interim CEO Michael Singer said in a press release.
Add Comment